Your session is about to expire
← Back to Search
Sternum Fixation Device
A Prospective, Single Center, Observational Study to Assess the Rapid Recovery After Cardiac Surgery Using SternaLock XP (RACE XP Trial)
N/A
Waitlist Available
Research Sponsored by Zimmer Biomet
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 days
Awards & highlights
No Placebo-Only Group
Summary
The primary objective of this study is to evaluate the post-operative rapid recovery in patients treated with SternaLock XP for rigid sternal fixation with sternal precautions less restrictive than standard of care.
Eligible Conditions
- Rigid Plate Fixation
- Median Sternotomy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Wound Infection
Secondary study objectives
Days alive and out of the hospital
Disability-free survival
Inspirometry vital capacity
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: SternaLock XPExperimental Treatment1 Intervention
Median sternotomy with rigid plate fixation (SternaLock XP) as the sole closure method
Find a Location
Who is running the clinical trial?
Zimmer BiometLead Sponsor
378 Previous Clinical Trials
68,050 Total Patients Enrolled